- Home
- LGND vs TENB Comparison
LGND vs TENB Comparison
Compare LGND & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGND | TENB |
|---|---|---|
| Founded | 1987 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LGND | TENB |
|---|---|---|
| Price | $288.15 | $34.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $256.29 | $31.69 |
| AVG Volume (30 Days) | 163.7K | ★ 3.6M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2886.36 | 3.23 |
| EPS | ★ 1.63 | 0.05 |
| Revenue | $141,102,000.00 | ★ $999,405,000.00 |
| Revenue This Year | $1.25 | $9.37 |
| Revenue Next Year | $19.41 | $7.04 |
| P/E Ratio | ★ $175.50 | $688.00 |
| Revenue Growth | ★ 29.48 | 11.04 |
| 52 Week Low | $161.82 | $15.73 |
| 52 Week High | $326.63 | $43.67 |
Technical Indicators
Market Signals| Indicator | LGND | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 46.74 |
| Support Level | $179.99 | $26.16 |
| Resistance Level | $317.49 | $40.19 |
| Average True Range (ATR) | 8.50 | 2.01 |
| MACD | -0.08 | -0.16 |
| Stochastic Oscillator | 46.12 | 36.11 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.